4 hours ago
SLS Stock Soars More Than 200% After Phase 3 Cancer Vaccine Success: What’s Next for SELLAS Life Sciences?

The post SLS Stock Soars More Than 200% After Phase 3 Cancer Vaccine Success: What’s Next for SELLAS Life Sciences? appeared first on Coinpedia Fintech News
SLS stock has skyrocketed more than 200%, putting SELLAS Life Sciences among the market’s biggest gainers after a major breakthrough in its Phase 3 cancer vaccine trial. The sharp rally followed results showing a 41% reduction in the risk of death among patients with acute myeloid leukemia, giving the company a potentially significant path toward …
Source: Coinpedia →Related News
- 1 hour ago
Is America Under A Digital Attack Right Now?
- 1 hour ago
Apple Outage Today Is Not A Cyberattack
- 2 hours ago
Dogecoin Sharks Quietly Accumulate Since September Despite Crypto Market Crash
- 3 hours ago
Ethereum Price Analysis: Are Whales Preparing for a Rebound as Retail Traders Ex...
- 3 hours ago
Basic Attention Token Price Prediction 2026, 2027-2030: Is BAT Token A Good Inve...
